News | Mammography | January 19, 2026

More than 1 million DBT studies from three manufacturers paired with biopsy outcome data for 22,000+ patients including more than 7,000 cancer cases.

Vega Curates Largest Digital Breast Tomosynthesis Dataset

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast tomosynthesis (DBT) dataset with paired histology outcomes. The dataset was prepared for a leading developer of AI-based radiology software focused on breast imaging and will support the development of next-generation AI solutions designed to assist in the interpretation of 3D mammography exams. The dataset includes over 1 million DBT studies across three DBT manufacturers, which are paired with biopsy outcome data for more than 22,000 patients, including over 7,000 cancer cases.  All data was de-identified according to 45 C.F.R. § 164.514(b) of the HIPAA Privacy Rule. 

Strengthening AI Performance 

DBT, or 3D mammography, has become an increasingly important technique in breast cancer screening, because it reduces overlapping breast tissue and improves lesion visibility as opposed to traditional 2D mammography techniques. At the same time, DBT exams generate hundreds of image slices per study, increasing interpretation time and cognitive load for radiologists.

By leveraging Vega’s large-scale imaging resources for this project, the AI developer was able to attain superior diversity in its data, which is a key factor in the development of models that are effective across a wide range of breast densities, anatomical variations, and real-world clinical conditions.

Large, Multi-Modal Imaging Datasets

“High-quality, clinically representative imaging data is essential for building AI tools that perform reliably in real-world care settings,” said Luke Bideaux, President and CEO of Vega Imaging Informatics. “This multi-modal dataset demonstrates Vega’s ability to deliver imaging data at scale while meeting the stringent quality, privacy, and compliance standards required for medical AI development. With a single DBT study reaching file sizes over 50 times larger than many other types of imaging studies, such as most chest x-rays, the sheer file size of this dataset demonstrates the scale Vega can achieve in its curation initiatives.” 

Next Generation of Breast Imaging Workflows

AI-enabled DBT interpretation tools are increasingly being adopted to support radiologists through improved workflow efficiency, reducing reading time, and enhancing diagnostic confidence. Increased adoption results in higher demand and competition for AI solutions that can deliver value to breast imaging providers. As the demand for large, high-quality imaging datasets continues to rise, Vega has proven that it is well positioned to meet the needs of the AI development community.

 

For more information visit vegainformatics.com


Related Content

News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Ultrasound Imaging

Feb. 25, 2026 — GE HealthCare is introducing the next generation of LOGIQ general imaging ultrasound systems – an ...

Time February 25, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
Subscribe Now